FOLH1 and neoplasm: Treatment of PC-3 PIP tumor-bearing mice showed an activity-dependent tumor growth inhibition and prolonged survival of mice which was more enhanced for [161Tb]Tb-PSMA-617 compared to [177Lu]Lu-PSMA-617 14.